Arcus Biosciences, Inc. (RCUS)
23.87
+0.13
(+0.55%)
USD |
NYSE |
May 21, 16:00
23.92
+0.04
(+0.19%)
After-Hours: 19:59
Arcus Biosciences Accounts Payable (Quarterly) : 39.00M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 645.00M |
| ACADIA Pharmaceuticals, Inc. | 12.25M |
| Alnylam Pharmaceuticals, Inc. | 126.63M |
| Amgen, Inc. | 2.935B |
| Catalyst Pharmaceuticals, Inc. | 7.151M |